Why Peninsula Research/ Benefits
Peninsula Research had a longstanding and great tradition for excellence forged in over a decade of doing business demonstrating our site to be a trustworthy and dependable partner. In March of 2013, our President and CEO, Angel I. Ribó PA-C, MAPS, AAHIVS purchased Peninsula Research. Having served as an investigator in over 100 multi-therapeutic trials and as a primary care provider and expert treater for HIV/AIDS patients since 1998 in Texas, Mr. Ribó has been able actively blending his expertise in the area of Infectious Diseases as well as his previous research network and experience in other multi-therapeutic areas, to the long standing history and tradition established by Peninsula Research since 2003. The acquisition of Peninsula Research by Ribó Research LLC, creates a unique synergy to develop this local research site to new and higher levels of participation in a larger number of trials in a greater number of therapeutic areas. By doing so we will be offering our community increased opportunities for cutting edge and adjunct care by trials that offer new options for care of multiple disease states. Our Investigators and staff are highly trained professionals whose primary goal is assisting those in our communities who are in need of this care, with safe and patient centered opportunities to add to their existing treatment options.
Experience
Peninsula Research is built on over 100 years of experience in the conduction of over 270 combined clinical trials by staff and investigators as well as from prior years of partnering within the pharmaceutical industry in the clinical research business. Most of our staff is comprised of certified professionals and our investigators are Board Certified in their specialty. Some of our extensive experience to date is listed below
Clinical Research Experience
• COPD
• Osteoarthritis
• Chronic Pain
• HIV/AIDS
• Infectious Diseases
• Hypertension
• Type 2 Diabetes
• Pneumonia
• Chronic Bronchitis
• Allergies
• Women’s Health
• Migraine Headaches
• Ulcerative Colitis
• Anemia
• Constipation
• Opioid Induced Constipation
• Irritable Bowel Syndrome
• Medication Application Devices
• Acne
• Fibromyalgia
• Asthma
• Hyperlipidemia
• Diabetic Peripheral Neuropathy
Sponsors:
• Abbott Laboratories
• AbbVie
• Adams Respiratory Therapeutics
• Adolor Pharmaceutical
• Alkermes, Inc.
• Alcon
• Altana, Inc.
• Altea Therapeutics
• Arena
• AstraZeneca
• Avexa
• Bayer Pharmaceuticals
• BoehringerIngelheim
• Bristol Meyer Squibb
• Cerimon
• Daiichi Sankyo Inc.
• Depomed
• Dynogen
• Endo Pharmaceuticals
• Epiphany Biosciences Inc.
• Forest Pharmaceutical
• Gilead Sciences
• GlaxoSmithKline
• Hoffman LaRoche Inc.
• Hormos Pharmaceutical
• Horizon Pharmaceuticals
• IMI
• Iroko Pharmaceutical, LLC
• Ironwood Pharmaceuticals
• Johnson and Johnson
• King Pharmaceutical
• Kadian
• Mead Johnson
• Merck & Co.
• Minster Research Ltd.
• Napo Pharmaceuticals
• NeurogesX
• NeuroMed Pharmaceutical
• NicOx
• Novartis Pharmaceuticals
• Novum Pharmaceutical
• Ortho-Biotech
• Pearl Therapeutics
• Penwest Pharmaceutical
• Pfizer, Inc.
• Pozen Pharmaceutical
• Proctor and Gamble
• Purdue Pharma L.P.
• QuatRx/Hormos
• Salix Pharmaceuticals
• Sanofi Aventis
• Schering- Plough
• SkyePharma
• Sucampo Pharmaceuticals
• Summers Loboratories
• TaiMed Biologics
• TakedaTanox
• Teva Branded Pharmaceutical
• Theravance
• Tibotec
• Tioga Pharmaceuticals
• Wyeth-Ayerst Pharmaceuticals
CROs
• Charles River Laboratories
• Cato
• Chiltern
• Covance
• CTMS
• Encorium
• Essential
• I3 Research
• ICON
• Inc Research
• Integrium
• InVentiv
• Kendle International
• K-Force
• Mayo Clinical Trials
• MDS Pharma Services
• Medpace
• Novum
• Paragon Biomedical
• Parexel
• Pharmalink
• PPD, Inc.
• Parexel
• PRA
• Premier Research Group
• Quintiles – Preferred Partner Site
• RPS
• Theorem Clinical
• Target Health, Inc.
• UBC
CONNECT